Insider Trading March 3, 2026

John B. Sanfilippo Insider Sells $583,954; Company Posts Strong Q2 Results

COO, President and Director Jasper Sanfilippo Jr. reduces stake under a 10b5-1 plan while JBSS reports Q2 EPS and revenue above expectations; valuation metrics highlight potential undervaluation

By Nina Shah JBSS
John B. Sanfilippo Insider Sells $583,954; Company Posts Strong Q2 Results
JBSS

Jasper Sanfilippo Jr., who serves as COO, President and a director at John B. Sanfilippo & Son Inc. (NASDAQ: JBSS), sold 7,212 shares of common stock on March 2, 2026, at $80.9698 per share for $583,954. After the transaction, he directly holds 29,048 shares. The sale was executed under a 10b5-1 trading plan. Separately, the company reported fiscal Q2 2026 earnings of $1.53 per share on $314.8 million in revenue, both modestly exceeding analyst expectations. Market metrics cited include a P/E of 13.49 and a PEG of 0.31, and InvestingPro analysis notes the stock appears undervalued relative to its Fair Value.

Key Points

  • Jasper Sanfilippo Jr. sold 7,212 shares on March 2, 2026, at $80.9698 per share for a total of $583,954 and now directly holds 29,048 shares.
  • The transaction was executed under a 10b5-1 trading plan, signaling a prearranged sale mechanism.
  • Fiscal Q2 2026 results exceeded expectations with EPS of $1.53 and revenue of $314.8 million; valuation metrics show a P/E of 13.49 and a PEG of 0.31, and InvestingPro flags the stock as undervalued relative to Fair Value.

Jasper Sanfilippo Jr., who holds the roles of chief operating officer, president and director at John B. Sanfilippo & Son Inc. (NASDAQ: JBSS), completed a sale of 7,212 shares of the company's common stock on March 2, 2026. The shares transacted at a per-share price of $80.9698, producing a gross value of $583,954. Following the disposition, Sanfilippo directly owns 29,048 shares of JBSS.

The transaction was carried out pursuant to a pre-established 10b5-1 trading arrangement. The use of a 10b5-1 plan indicates the sale was executed under terms set out in advance, though the plan itself is the only procedural detail disclosed.


Valuation snapshot and research access

Current market metrics cited for the company include a price-to-earnings ratio of 13.49 and a relatively low price/earnings-to-growth (PEG) ratio of 0.31. According to InvestingPro analysis referenced in company coverage, JBSS is assessed as trading below its estimated Fair Value. Investors seeking detailed coverage can consult the InvestingPro Pro Research Report for JBSS, which is among the more than 1,400 US equities included in that service.


Recent financial performance

John B. Sanfilippo & Son Inc. reported fiscal second-quarter 2026 results that beat consensus expectations on both the top and bottom lines. The company delivered earnings per share of $1.53, compared with analysts' estimates of $1.36. Revenue for the quarter totaled $314.8 million, modestly above the $313.4 million that had been forecast.

Those results are presented here as reported. The company and its results are described as having outperformed market projections for the quarter, a fact that is likely to shape investor sentiment and could be considered in further research and valuation analyses.


Summary and context

The disclosed insider sale and the contemporaneous quarterly results are separate facts: an executive-level share sale executed through a 10b5-1 plan, and quarterly financials that exceeded expectations. The valuation metrics and InvestingPro commentary provide additional data points that market participants may use in constructing their assessments of JBSS.

Key points

  • Jasper Sanfilippo Jr. sold 7,212 shares on March 2, 2026, at $80.9698 per share for a total of $583,954; he now directly owns 29,048 shares.
  • The sale was executed pursuant to a 10b5-1 trading plan, indicating pre-arranged terms for the disposition.
  • John B. Sanfilippo & Son reported fiscal Q2 2026 EPS of $1.53 and revenue of $314.8 million, each slightly above analyst forecasts; market metrics include a P/E of 13.49 and a PEG of 0.31.

Risks and uncertainties

  • Insider transactions, even when pre-planned under 10b5-1 arrangements, can prompt investor scrutiny and may affect short-term stock sentiment in US equities markets.
  • Valuation indicators cited are one input among many; differing methodologies could change assessments of under- or overvaluation and thus influence investor decisions.
  • Quarterly outperformance is a single reporting period; future results and analyst ratings may vary and could alter market perceptions.

Risks

  • Insider sales, even under 10b5-1 plans, can affect investor sentiment in US equities and corporate governance evaluations.
  • Valuation assessments depend on methodology; the cited P/E and PEG ratios may not capture all valuation dynamics and could lead to differing investor conclusions.
  • Quarterly beats represent a single period; subsequent performance or analyst revisions could change market perception.

More from Insider Trading

Hercules Capital Director Adds $45,079 Worth of Shares, Boosting Stake to 19,560 Mar 6, 2026 ResMed Director Disposes $520K in Shares as Company Posts Modest Beat on EPS Mar 6, 2026 Healthcare Realty CFO Makes Modest Share Purchase as Q4 Results Exceed Estimates Mar 6, 2026 RENN Fund Co-Portfolio Manager Adds to Position With $584 Purchase Mar 5, 2026 Lattice Semiconductor SVP Executes $3.49M Stock Sale Under Prearranged 10b5-1 Plan Mar 5, 2026